Programmed cell death 1 pathway inhibitors improve the overall survival of small cell lung cancer patients with brain metastases

PURPOSE: The objective of this study was to evaluate the safety and efficacy of immune checkpoint inhibitors in small cell lung cancer patients with brain metastases. METHODS: We retrospectively reviewed the records of small cell lung cancer patients with brain metastases treated with chemotherapy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, JiaYu, Jing, XuQuan, Hua, Ying, Geng, KaiXing, Li, RuYue, Lu, ShuangQing, Zhu, Hui, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097768/
https://www.ncbi.nlm.nih.gov/pubmed/35737093
http://dx.doi.org/10.1007/s00432-022-04121-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097768/
https://www.ncbi.nlm.nih.gov/pubmed/35737093
http://dx.doi.org/10.1007/s00432-022-04121-y

Ejemplares similares